Murdock Hunter R.'s Form 4 filing
Axsome Therapeutics, Inc.AXSM · filed Jun 18, 2025
- Accession no.
- 0000950170-25-088105
- Filed
- Jun 18, 2025
- Trade date
- Jun 16-18, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.28M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Murdock Hunter R.CIK 0001934008 | Officer (General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2025 | Common Stock | MOption exerciseAcquired | +7,500 | $29.91 | +$224,325 | 7,500 | Direct | |
| Jun 16, 2025 | Common Stock | SSaleDisposed | −7,500 | $102.42F3 | −$768,150 | 0 | Direct | |
| Jun 17, 2025 | Common Stock | MOption exerciseAcquired | +7,500 | $29.91 | +$224,325 | 7,500 | Direct | |
| Jun 17, 2025 | Common Stock | SSaleDisposed | −7,500 | $100.26F4 | −$751,950 | 0 | Direct | |
| Jun 18, 2025 | Common Stock | MOption exerciseAcquired | +7,500 | $29.91 | +$224,325 | 7,500 | Direct | |
| Jun 18, 2025 | Common Stock | SSaleDisposed | −7,500 | $100.90F5 | −$756,750 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2025 | Common Stock | MOption exerciseDisposed | −7,500 | $0.00 | $0 | 44,883 | Direct | |
| Jun 17, 2025 | Common Stock | MOption exerciseDisposed | −7,500 | $0.00 | $0 | 37,383 | Direct | |
| Jun 18, 2025 | Common Stock | MOption exerciseDisposed | −7,500 | $0.00 | $0 | 29,883 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $101.01 and $104.09
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $100.00 and $101.53.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $100.00 and $101.96.
Referenced by the price of 1 transaction in Table I.